《大行報告》美銀證券升富途控股(FUTU.US)目標價至44.5美元 評級「跑輸大市」
美銀證券發表研究報告指,線上券商「富途證券」母企富途控股(FUTU.US)首季GAAP(通用會計準則)純利按季升14.6%至5.72億港元,收入按季升2%至16億港元,較該行預期高3%及6%。該行升其2022至2024年盈測介乎24%至26%,目標價升11%,由40美元上調至44.5美元,反映首季業績良好及近期資本市場表現改善。維持「跑輸大市」評級,認為其盈利及股價表現與股市表現高度關連,而近期股市復甦的可持續性有待觀察。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.